HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shahzad G. Raja Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Raja, S. G. Search for Related Content PubMed PubMed Citation Articles by Raja, S. G. Related Collections Cardiac - pharmacology Coronary disease Extracorporeal circulation Minimally invasive surgery

J Thorac Cardiovasc Surg 2005;129:475
© 2005 The American Association for Thoracic Surgery

Letters to the Editor

Reasons for inability of clopidogrel to inhibit platelet aggregation early after coronary artery bypass surgery

Department of Cardiac Surgery, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ, United Kingdom

The first 20% of the full text of this article appears below.

To the Editor:

Clopidogrel administration for platelet inhibition after coronary artery surgery and interventional cardiology is currently a topic of much-deserved attention and debate. I read with interest the recent article in the Journal by Lim and colleagues.¹ On the basis of the results of an interim analysis of their prospective, double-blind, randomized, controlled trial to compare the efficacy of clopidogrel and aspirin as antiplatelet agents, Lim and colleagues . . . [Full Text of this Article]